Twist Bioscience
Interpace Biosciences, Miroculus, Twist Bioscience Partner to Automate NGS Library Prep in Cancer Dx
The three companies join forces to automate sample preparation for genetic testing of endocrine and GI cancers using digital microfluidics technology.
Ansa Biotechnologies Accelerating Enzymatic DNA Synthesis Technology as a Commercial Service
Premium
The University of California, Berkeley spinout hopes to stand out in the synthetic DNA race using its polymerase-nucleotide conjugation approach.
In Brief This Week: Cardea Bio, Proof Diagnostics, Ginkgo Bioworks, Twist Bioscience, More
News items for the week of April 4, 2022.
Twist Bioscience, Ginkgo Bioworks Sign New Synthetic DNA Supply Agreement
Under the four-year deal, Ginkgo has increased its commitment to purchase products from Twist and has an option to access "significantly more synthesis capacity."
Jan 3, 2022
GW Index Rises 3 Percent in December
Sep 8, 2021